Cis-disamminedichloroplatinum (II) CDDP: single agent in the treatment of advanced head and neck squamous cell carcinoma.
Seventeen patients with head and neck squamous cell carcinoma were treated with cis-diamminedichloroplatinum (II) CDDP 2.5 mg./kg. I.V. as a single agent. One complete and five partial responses were observed with only moderate toxicity.
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D002945:Cisplatin